Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
Conditions
Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mount Sinai Medical Center, Miami Beach, Florida, United States
USF College of Medicine, Tampa, Florida, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Beth Israel Lahey Health, Burlington, Massachusetts, United States
Overlook Medical Center, Summit, New Jersey, United States
Mater Hospital Sydney, North Sydney, New South Wales, Australia
Monash Medical Centre Moorabbin, East Bentleigh, Victoria, Australia
GenesisCare St Andrews Hospital, Adelaide, Australia
Fiona Stanley Hospital, Murdoch, Australia
Institut Jules Bordet, Anderlecht, Belgium
GZA Ziekenhuizen, Antwerp, Belgium
Universitair Ziekenhuis Brussel, Brussels, Belgium
Cliniques Universitaires Saint-Luc, Brussels, Belgium
UZ Leuven, Leuven, Belgium
Centre Hospitalier Universitaire de Liege Sart-Tilman, Liège, Belgium
GZA Ziekenhuizen, Wilrijk, Belgium
Centro de Oncologia - Unidade Brasília - Hospital Sírio Libanês, Brasília, Brazil
CIONC-Centro Integrado de Oncologia de Curitiba, Curitiba, Brazil
Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer, Curitiba, Brazil
CEPON - Centro de Pesquisas Oncológicas de Santa Catarina, Florianópolis, Brazil
Oncosite - Centro de Pesquisa Clinica e Oncologia, Ijuí, Brazil
Fundação Doutor Amaral Carvalho, Jaú, Brazil
Instituto de Cancer de Londrina, Londrina, Brazil
Hospital das Clínicas FMRP-USP, Riberão Preto, Brazil
Hospital Nossa Senhora da Conceicao, Rio Grande, Brazil
Ensino e Terapia de Inovação Clínica AMO-ETICA, Salvador, Brazil
Catarina Pesquisa Clinica, Santa Catarina, Brazil
CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia, Santo André, Brazil
Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto, São José do Rio Preto, Brazil
ICESP - Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, São Paulo, Brazil
Clínica de Pesquisas e Centro de Estudos em Oncologia Ginecológica e Mamária Ltda, São Paulo, Brazil
Beijing Hospital, Beijing, China
307 Hospital of PLA, Beijing, China
Contact: Study coordinator (Principal Investigator)Fujian Cancer Hospital, Fujian, China
Sun Yat sen University Cancer Center, Guangzhou, China
Zhejiang Cancer Hospital, Hangzhou, China
Anhui Provincial Cancer Hospital, Hefei, China
Shandong Cancer Hospital, Jinan, China
Yunnan Cancer Hospital, Kunming, China
Nanchang People's Hospital, Nanchang, China
Jiangxi Cancer Hospital, Nanchang, China
The Affiliated Hospital of Qingdao University, Qingdao, China
Fudan University Shanghai Cancer Center, Shanghai, China
Contact: Study coordinator (Principal Investigator)Henan Cancer Hospital, Zhengzhou, China
Cork University Hospital, Cork, Ireland
St Vincent's University Hospital, Dublin, Ireland
St James Hospital, Dublin, Ireland
Contact: Study coordinator (Principal Investigator)Beaumont Hospital, Dublin, Ireland
Contact: Study coordinator (Principal Investigator)Galway University Hospital, Galway, Ireland
Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari, Bari, Italy
Azienda Ospedaliera Universitaria Policlinico Sant Orsola Malpighi IRCCS, Bologna, Italy
Istituto Nazionale per la Ricerca sul Cancro di Genova, Genova, Italy
Ospedale San Raffaele, Milan, Italy
Humanitas Istituto Clinico Catanese, Misterbianco, Italy
Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy
IOV - Istituto Oncologico Veneto IRCCS, Padova, Italy
Nuovo Ospedale di Prato, Prato, Italy
Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza, Rome, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Contact: Study coordinator (Principal Investigator)Ospedale Santa Chiara, Trento, Italy
Amsterdam UMC, Locatie VUMC, Amsterdam, Netherlands
Amphia Ziekenhuis Molengracht, Breda, Netherlands
Medisch Centrum Leeuwarden, Leeuwarden, Netherlands
Alrijne Ziekenhuis Leiden, Leiden, Netherlands
Contact: Study coordinator (Principal Investigator)Maastricht University Medical Center, Maastricht, Netherlands
Haga Ziekenhuis, The Hague, Netherlands
Elisabeth TweeSteden Ziekenhuis, Tilburg, Netherlands
Bernhoven Uden, Uden, Netherlands
Contact: Study coordinator (Principal Investigator)Hospital de Braga, Braga, Portugal
Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE, Lisbon, Portugal
Fundação Champalimaud, Lisbon, Portugal
Centro Hospitalar de Lisboa Norte E P E Hospital de Santa Maria, Lisbon, Portugal
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
ICO l'Hospitalet - Hospital Duran i Reynals, Barcelona, Spain
Hospital Universitario Donostia, Donostia / San Sebastian, Spain
Hospital Universitario Virgen de las Nieves, Granada, Spain
Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain
Hospital Beata Maria Ana, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain
Hospital General Universitario Morales Meseguer, Murcia, Spain
Clinica Universidad de Navarra, Pamplona, Spain
Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
Hospital Universitario Virgen Macarena, Seville, Spain
Hospital Clinico Universitario de Valencia, Valencia, Spain
Hospital Arnau de Vilanova de Valencia, Valencia, Spain
Study leads
Global Clinical Leader
Study Director
Daiichi Sankyo